JP2008545670A5 - - Google Patents

Download PDF

Info

Publication number
JP2008545670A5
JP2008545670A5 JP2008512729A JP2008512729A JP2008545670A5 JP 2008545670 A5 JP2008545670 A5 JP 2008545670A5 JP 2008512729 A JP2008512729 A JP 2008512729A JP 2008512729 A JP2008512729 A JP 2008512729A JP 2008545670 A5 JP2008545670 A5 JP 2008545670A5
Authority
JP
Japan
Prior art keywords
formula
compound
alkyl
substituted
combination according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008512729A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008545670A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/004523 external-priority patent/WO2006125539A2/en
Publication of JP2008545670A publication Critical patent/JP2008545670A/ja
Publication of JP2008545670A5 publication Critical patent/JP2008545670A5/ja
Pending legal-status Critical Current

Links

JP2008512729A 2005-05-27 2006-05-13 疾患を処置するためのジアリールウレア類を含む組合せ治療 Pending JP2008545670A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05011476 2005-05-27
EP05011478 2005-05-27
EP05011475 2005-05-27
PCT/EP2006/004523 WO2006125539A2 (en) 2005-05-27 2006-05-13 Combination therapy comprising diaryl ureas for treating diseases

Publications (2)

Publication Number Publication Date
JP2008545670A JP2008545670A (ja) 2008-12-18
JP2008545670A5 true JP2008545670A5 (cg-RX-API-DMAC7.html) 2009-05-07

Family

ID=37052960

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008512729A Pending JP2008545670A (ja) 2005-05-27 2006-05-13 疾患を処置するためのジアリールウレア類を含む組合せ治療

Country Status (10)

Country Link
US (1) US20090306020A1 (cg-RX-API-DMAC7.html)
EP (1) EP1888065A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008545670A (cg-RX-API-DMAC7.html)
KR (1) KR20080012902A (cg-RX-API-DMAC7.html)
AU (1) AU2006251428A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0610090A2 (cg-RX-API-DMAC7.html)
CA (1) CA2609387A1 (cg-RX-API-DMAC7.html)
IL (1) IL187085A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007014920A (cg-RX-API-DMAC7.html)
WO (1) WO2006125539A2 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP2298311B1 (en) 1999-01-13 2012-05-09 Bayer HealthCare LLC w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
DK1478358T3 (da) 2002-02-11 2013-10-07 Bayer Healthcare Llc Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
EP1636585B2 (en) 2003-05-20 2012-06-13 Bayer HealthCare LLC Diaryl ureas with kinase inhibiting activity
PL1663978T3 (pl) 2003-07-23 2008-04-30 Bayer Healthcare Llc Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów
US20110008327A1 (en) 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
DE602006017188D1 (de) * 2005-03-07 2010-11-11 Bayer Schering Pharma Ag Pharmazeutische zusammensetzung mit einem omega-carboxyaryl-substituierten diphenylharnstoff zur behandlung von krebs
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
TW200835507A (en) * 2006-12-05 2008-09-01 Vioquest Pharmaceuticals Inc Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
ES2429107T3 (es) 2007-01-19 2013-11-13 Bayer Healthcare Llc Tratamiento de cánceres con una resistencia adquirida a los agentes inhibidores de KIT
US7947723B2 (en) 2008-02-01 2011-05-24 Spelman College Synthesis and anti-proliferative effect of benzimidazole derivatives
WO2009126415A1 (en) * 2008-04-09 2009-10-15 Dow Global Technologies Inc. Multi-stage process and apparatus for recovering dichlorohydrins
TW201012467A (en) 2008-09-16 2010-04-01 Taiho Pharmaceutical Co Ltd Antitumor agent containing 4-[[3,5-bis(trimethylsilyl)benzoyl]amino]benzoic acid
US20120046333A1 (en) * 2009-04-09 2012-02-23 Oncothyreon Incorporated Methods and Compositions of PI-3 Kinase Inhibitors for Treating Fibrosis
CN102713618B (zh) 2009-09-16 2015-07-15 新基阿维罗米克斯研究公司 蛋白激酶复合物和抑制剂
WO2011082285A1 (en) 2009-12-30 2011-07-07 Avila Therapeutics, Inc. Ligand-directed covalent modification of protein
ES2385276B1 (es) * 2010-02-25 2013-07-05 Universidad Del País Vasco Compuestos para el tratamiento de alzheimer.
JP2013531067A (ja) 2010-07-19 2013-08-01 バイエル ヘルスケア リミティド ライアビリティ カンパニー 疾病及び状態の処置及び予防のためのフルオロ置換オメガ−カルボキシアリールジフェニル尿素を用いた組み合わせ薬
BR112016014481B1 (pt) * 2013-12-20 2022-11-08 Biomed Valley Discoveries, Inc Uso de uma composição farmacêutica, método in vitro para efetuar a morte de células cancerosas, e kit
WO2015095842A2 (en) 2013-12-20 2015-06-25 Biomed Valley Discoveries, Inc. Methods and compositions for treating non-erk mapk pathway inhibitor-resistant cancers
CN114751899B (zh) * 2022-04-24 2024-03-29 贵州医科大学 一种二芳基脲类mTOR激酶抑制剂及其药物组合物和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378725A (en) * 1993-07-19 1995-01-03 The Arizona Board Of Regents Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
EP1140840B1 (en) * 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
DK1478358T3 (da) * 2002-02-11 2013-10-07 Bayer Healthcare Llc Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
WO2003086279A2 (en) * 2002-04-08 2003-10-23 Merck & Co., Inc. Inhibitors of akt activity
PL1663978T3 (pl) * 2003-07-23 2008-04-30 Bayer Healthcare Llc Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów
MXPA06010667A (es) * 2004-03-19 2007-07-04 Penn State Res Found Metodos combinatorios y composiciones para el tratamiento de melanoma.
JP5334414B2 (ja) * 2004-09-06 2013-11-06 バイエル インテレクチュアル プロパティー ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規のピラゾロピリミジン

Similar Documents

Publication Publication Date Title
JP2008542214A5 (cg-RX-API-DMAC7.html)
EP2370076B1 (en) Pharmaceutical combination comprising a Hsp 90 inhibitor and a mTOR inhibitor
ES2638980T3 (es) Compuestos y composiciones farmacéuticas de los mismos para el tratamiento de trastornos inflamatorios
RU2007148266A (ru) Комбинированная терапия с использованием соединения диарилмочевины и ингибиторов pi3, akt-киназы или mtor (рапамицины) для лечения рака
JP7184646B2 (ja) ビアリールモノバクタム化合物および細菌感染治療のためのそれの使用方法
ES2643379T3 (es) Nuevas dihidropirimidinoisoquinolinonas y sus composiciones farmacéuticas para el tratamiento de trastornos inflamatorios
DK3191477T3 (en) USEFUL CONDENSED BICYCLEIC (HETERO) AROMATIC COMPOUNDS IN CANCER TREATMENT
CA3124678A1 (en) Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancer
EP3423451A1 (en) Inhibitors of wdr5 protein-protein binding
JPH05148271A (ja) ラパマイシンのアミドエステル類
RU2006137794A (ru) Химические составы, композиции и способы их использования
RU2012136643A (ru) [5,6]- гетероциклическое соединение
JP2014506599A5 (cg-RX-API-DMAC7.html)
CN113660931B (zh) 用于治疗皮肤癌的芳基苯胺和杂芳基苯胺化合物
RU2011110691A (ru) Способ получения ингибиторов sglt2
JP2011522866A5 (cg-RX-API-DMAC7.html)
US9518055B2 (en) Imidazopyridyl compounds as aldosterone synthase inhibitors
AR057848A1 (es) Diarilureas para el tratamiento de la hipertension pulmonar
JP2008537930A5 (cg-RX-API-DMAC7.html)
JP2008545670A (ja) 疾患を処置するためのジアリールウレア類を含む組合せ治療
KR102005121B1 (ko) 2-아미노-3-(이미다졸-2-일)-피리딘-4-온 유도체 및 vegf 수용체 키나제 억제제로서의 그의 용도
CN120457125A (zh) 靶向Polθ的化合物及其用途
JP2024516429A (ja) メチオニンアデノシルトランスフェラーゼ阻害剤、その調製方法およびその適用
RU2008115512A (ru) ИНГИБИТОРЫ МЕТАЛЛО-β-ЛАКТАМАЗЫ
MX2011005003A (es) Inhibidor de p70 s6 quinasa y terapia de combinacion de inhibidor de mtor.